tiprankstipranks
Advertisement
Advertisement
enGene stops enrollment in additional LEGEND cohorts to conserve cash
PremiumThe FlyenGene stops enrollment in additional LEGEND cohorts to conserve cash
24d ago
enGene reports Q2 EPS (43c), consensus (47c)
Premium
The Fly
enGene reports Q2 EPS (43c), consensus (47c)
24d ago
enGene implements plan to reduce workforce by 50%
Premium
The Fly
enGene implements plan to reduce workforce by 50%
24d ago
enGene downgraded to Perform from Outperform at Oppenheimer
PremiumThe FlyenGene downgraded to Perform from Outperform at Oppenheimer
2M ago
enGene downgraded to Market Perform from Outperform at Leerink
Premium
The Fly
enGene downgraded to Market Perform from Outperform at Leerink
2M ago
Leland Gershell Reiterates Hold on enGene as LEGEND Trial Efficacy Declines and Withdraws Sales Forecasts and Price Target Pending Greater Clarity
Premium
Ratings
Leland Gershell Reiterates Hold on enGene as LEGEND Trial Efficacy Declines and Withdraws Sales Forecasts and Price Target Pending Greater Clarity
2M ago
enGene downgraded to Equal Weight from Overweight at Wells Fargo
PremiumThe FlyenGene downgraded to Equal Weight from Overweight at Wells Fargo
2M ago
enGene downgraded to Equal Weight from Overweight at Morgan Stanley
Premium
The Fly
enGene downgraded to Equal Weight from Overweight at Morgan Stanley
2M ago
enGene downgraded to Neutral from Buy at Guggenheim
Premium
The Fly
enGene downgraded to Neutral from Buy at Guggenheim
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100